Sarcoma  >>  Jeselhy (pimitespib)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jeselhy (pimitespib) / Otsuka
NCT04999761: AB122 Platform Study

Recruiting
1
715
Japan
AB122, TAS-116, TAS-120, TAS-115, TAS-102, Ramucirumab, Bevacizumab
Taiho Pharmaceutical Co., Ltd.
Advanced or Metastatic Solid Tumor, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Non-small Cell Lung Cancer, Gastric Cancer, Alveolar Soft Part Sarcoma
05/26
05/26
BrUOG 387, NCT05655598: TAS-116 Plus Palbociclib in Breast and Rb-null Cancer

Recruiting
1
27
US
Palbociclib Oral Product, TAS-116
Brown University
Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency, SCLC, Soft Tissue Sarcoma, Endometrial Cancer, Bladder Cancer
08/24
08/25
CHAPTER-GIST-101, NCT05245968: A Study of Pimitespib in Combination With Imatinib in Patients With GIST

Recruiting
1
78
Japan, RoW
Pimitespib, TAS-116, Imatinib, Sunitinib
Taiho Pharmaceutical Co., Ltd.
Gastrointestinal Stromal Tumors
12/25
12/25

Download Options